145 related articles for article (PubMed ID: 37282898)
21. [Construction of model for multidimensional evaluation of value and risk of Chinese patent medicine].
Li G; Li ZK; Yang HJ; Zhan ZL; Li HM; Tang SH
Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(5):1284-1292. PubMed ID: 33787124
[TBL] [Abstract][Full Text] [Related]
22. Chinese patent medicine for functional dyspepsia effects: A protocol for systematic review and Bayesian network meta-analysis.
Wu J; Wei Y; Chen Y; Long Y; Huang N; Mei Y
Medicine (Baltimore); 2021 Nov; 100(47):e27761. PubMed ID: 34964734
[TBL] [Abstract][Full Text] [Related]
23. [Clinical trials and evaluation of Chinese patent medicine for stroke].
Feng CN; Ji ZC; Peng DH; Hu HY; Zhang JH; Pang B
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2330-2337. PubMed ID: 35531680
[TBL] [Abstract][Full Text] [Related]
24. Identification of Calculus Bovis and its mixed varieties by ultra-high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UHPLC-Q/TOF-MS) combined with the principal component analysis (PCA) method.
Liu WX; Cheng XL; Guo XH; Hu XR; Wei F; Ma SC
J Pharm Biomed Anal; 2020 Feb; 179():112979. PubMed ID: 31825798
[TBL] [Abstract][Full Text] [Related]
25. [Scoping review of clinical evidence of Chinese patent medicines for digestive system diseases in children].
Wu X; Dai ZQ; Xu SM; Li MM; Liao X
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4248-4255. PubMed ID: 36046915
[TBL] [Abstract][Full Text] [Related]
26. [Network Meta-analysis of efficacy and safety of oral Chinese patent medicines combined with conventional western medicine in treatment of hypertension].
Ji ZC; Lin SS; Hu HY; Sheng XD; Yang FW; Wang XL
Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(7):1955-1988. PubMed ID: 35534266
[TBL] [Abstract][Full Text] [Related]
27. [Network Meta-analysis of Chinese patent medicines of Ziziphi Spinosae Semen in treatment of primary insomnia].
Yao WQ; Zhao YH; Zheng YW; Zhang Q; Han X
Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4541-4554. PubMed ID: 34581060
[TBL] [Abstract][Full Text] [Related]
28. [Network Meta-analysis of oral blood-activating and stasis-removing Chinese patent medicines in treatment of hypertensive left ventricular hypertrophy].
Zheng YW; Li J; Yao WQ; Pan MY; Fang Y
Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(5):1383-1391. PubMed ID: 35343167
[TBL] [Abstract][Full Text] [Related]
29. [Exploration and practice of post-marketing survival benefit evaluation of Chinese patent medicine for cancer].
Xu BW; Wu JY; Li J; Zhang Y; Cao LC; Zhang XX; Gao RK
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):1980-1987. PubMed ID: 33982508
[TBL] [Abstract][Full Text] [Related]
30. [Network Meta-analysis of Chinese patent medicine containing Hirudo in treatment of atherosclerosis].
Han QQ; Wen ZY; Lyu Q; Pan YY
Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):234-246. PubMed ID: 36725276
[TBL] [Abstract][Full Text] [Related]
31. [Evidence mapping of Chinese patent medicines in treatment of premature ventricular contractions].
Zhang WJ; Tang JW; Li J; Wu J; Zhang YM; Xie ZC; Zhang LS; Meng C; Huang XC
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1397-1405. PubMed ID: 38621988
[TBL] [Abstract][Full Text] [Related]
32. Exploring the pharmacological mechanism of calculus bovis in cerebral ischaemic stroke using a network pharmacology approach.
Du X; Li C; Zhang S; Sun C; Zhang X; Chen C; Wang X; Cheng F; Wang Q
J Ethnopharmacol; 2022 Feb; 284():114507. PubMed ID: 34384847
[TBL] [Abstract][Full Text] [Related]
33. [Clinical trials and evaluation of Chinese patent medicine for chronic obstructive pulmonary disease].
Feng CN; Hu HY; Ji ZC; Qiang XY; Chen Z; Ou Y; Cao LJ; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2351-2357. PubMed ID: 35531683
[TBL] [Abstract][Full Text] [Related]
34. [Clinical trials and evaluation of Chinese patent medicine for heart failure].
Wu XL; Qiang XY; Ji ZC; Hu HY; Feng CN; Wang DL; Peng DH; Cao LJ; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2322-2329. PubMed ID: 35531679
[TBL] [Abstract][Full Text] [Related]
35. [Design and implementation of supply security monitoring and analysis system for Chinese patent medicines supply in national essential medicines].
Wang H; Zhang XB; Huang LQ; Guo LP; Wang L; Zhao YP; Yang G
Zhongguo Zhong Yao Za Zhi; 2017 Nov; 42(22):4310-4313. PubMed ID: 29318827
[TBL] [Abstract][Full Text] [Related]
36. [Multi-dimensional mining and analysis of core prescriptions in launched Chinese patent medicine for treatment of influenza].
Gu H; He WJ; Wei PL; Dang HX; You RL; Liu J; Wang Z
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(21):4738-4744. PubMed ID: 31872672
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of oral traditional Chinese patent medicine in treatment of liver stagnation and spleen deficiency of depression: A protocol for systematic review.
Yu Y; Zhang G; Han T; Huang H
Medicine (Baltimore); 2020 Feb; 99(7):e19142. PubMed ID: 32049837
[TBL] [Abstract][Full Text] [Related]
38. [Network Meta-analysis of Chinese patent medicine in treatment of unstable angina pectoris].
Zhang LM; DU TH; Niu LL; Wang LY; Li JN; Ma PF; Yu R
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):703-711. PubMed ID: 33645038
[TBL] [Abstract][Full Text] [Related]
39. Traditional Chinese medicine decoctions and Chinese patent medicines for the treatment of depression: Efficacies and mechanisms.
Zhuang W; Liu SL; Xi SY; Feng YN; Wang K; Abduwali T; Liu P; Zhou XJ; Zhang L; Dong XZ
J Ethnopharmacol; 2023 May; 307():116272. PubMed ID: 36791924
[TBL] [Abstract][Full Text] [Related]
40. [Application of Chinese patent medicines for external-contraction febrile disease in Medical Records Integration of Palace in Qing Dynasty].
Leung KP; Ji YK; Chen GS; Liu G
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(20):5662-5669. PubMed ID: 36471984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
